DR. AZAD KUMAR SINGH; DR. SATISH KUMAR YADAV; MS. SONAM VERMA; DR. PRINC BGHEAL. IMPACT OF TYPE 2 DIABETES MELLITUS ON RIFAMPICIN PHARMACOKINETICS AND BIOCHEMICAL PATHWAYS IN PULMONARY TUBERCULOSIS PATIENTS. Journal of Population Therapeutics and Clinical Pharmacology, [S. l.], v. 32, n. 7, p. 1149–1153, 2025. DOI: 10.53555/gcv48408. Disponível em: https://www.jptcp.com/index.php/jptcp/article/view/11052. Acesso em: 29 sep. 2025.